Additional data from BROADWAY, BROOKLYN, and TANDEM to be presented throughout 2025; expected to support global regulatory filings for obicetrapib, including EMA submission in 2H25 by our partner ...
TVS Holdings (TVSHL) stated that CRISIL Ratings has upgraded its rating on the long-term bank facility and non-convertible debentures (NCDs) of the company to 'CRISIL AA+/Stable' from 'CRISIL ...